Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

white/kiharusi

Kiungo kimehifadhiwa kwenye clipboard
11 matokeo
CROSS REFERENCE TO PRIOR APPLICATIONS This application is a National Stage Application of PCT International Patent Application No. PCT/KR2013/007825 filed on Aug. 30, 2013, under 35 U.S.C. .sctn. 371, which claims priority to Korean Patent Application No. 10-2013-0014520 filed on Feb. 8, 2013, which

Use of endogenous antioxidant proteins in the treatment of stroke

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF INVENTION This invention relates to treatment of CNS damage. Specifically, the invention provides for upregulating anti-oxidant proteins in neurons to effect treatment, and prevent neuronal damage. BACKGROUND OF THE INVENTION Stroke is the third leading cause of death in the United States,

Differential expression of molecules associated with acute stroke

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD This application relates to methods of evaluating an ischemic stroke, methods of identifying a treatment modality for a subject who has had an ischemic stroke, methods of identifying compounds that alter the activity of an ischemic stroke-related molecule, as well as arrays and kits that can
FIELD OF INVENTION This invention relates to stroke treatment. Specifically, the invention discloses a novel treatment of stroke using sigma receptors. BACKGROUND OF THE INVENTION Stroke poses a significant healthcare burden in this country as it is the fourth leading cause of death and results in a

Intelligent whiteboard collaboratio systems and methods

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE DISCLOSURE The present disclosure relates in general to videoconferencing with whiteboard. Specifically, the present disclosure relates to systems and methods for capturing time-stamped whiteboard data and producing high-resolution whiteboard images. More specifically, an

Alpha-aminoamide derivatives useful in the treatment of cognitive disorders

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS-REFERENCE TO RELATED APPLICATIONS This is the .sctn.371 U.S. national stage of International Application No. PCT/EP2007/005197, filed Jun. 13, 2007, which claims the benefit of European patent application no. 06012352.8, filed Jun. 15, 2006, the disclosures of which are incorporated herein by

Systems and methods for treating medical conditions by stimulation of medial thalamic region

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD The present invention relates to methods of treating medical conditions by electrical and/or chemical neuromodulation of target sites in the nervous system. BACKGROUND Neuromodulation involves an array of therapeutic approaches applied to the brain, cranial nerves, spinal cord and

Therapeutic morpholino-substituted compounds

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

Therapeutic morpholino-substituted compounds

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

Therapeutic morpholino-substituted compounds

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

Ophthermometry: a method of measuring eye temperature for diagnosis and surgery

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE PRESENT INVENTION Strokes are the third leading killer of adults in this nation after cancer and heart disease. Half the survivors suffer permanent incapacitating disabilities. Over 40 percent of the patients in chronic care are stroke victims, many destined to spend their lives in
Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge